Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-010101
Filing Date
2022-05-16
Accepted
2022-05-16 16:31:42
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iobt-20220331.htm   iXBRL 10-Q 1607415
2 EX-31.1 iobt-ex31_1.htm EX-31.1 19862
3 EX-31.2 iobt-ex31_2.htm EX-31.2 19682
4 EX-32.1 iobt-ex32_1.htm EX-32.1 11923
5 EX-32.2 iobt-ex32_2.htm EX-32.2 11743
6 GRAPHIC img133099476_0.jpg GRAPHIC 134681
  Complete submission text file 0000950170-22-010101.txt   5989879

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT iobt-20220331_cal.xml EX-101.CAL 39387
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iobt-20220331_def.xml EX-101.DEF 140889
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iobt-20220331_pre.xml EX-101.PRE 249044
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iobt-20220331_lab.xml EX-101.LAB 333268
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iobt-20220331.xsd EX-101.SCH 39051
58 EXTRACTED XBRL INSTANCE DOCUMENT iobt-20220331_htm.xml XML 878948
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41008 | Film No.: 22929808
SIC: 2834 Pharmaceutical Preparations